Log In
Print this Print this

AL 408

  Manage Alerts
Collapse Summary General Information
Company Endo International plc
DescriptionD-amino acid derivative of AL-108
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationNerve damage
Indication DetailsTreat neurodegenerative conditions
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today